NPM1 and acute myeloid leukemia: These in vitro data suggest that the NPM1 mutational status has a potential different contribution on the aggressiveness of AML cells, since the over-expression of HOX genes was previously described to be correlated with poor survival of NPM1-mutated AML patients [31].